Supplementary Methods from Oncogenic NRAS, Required for Pathogenesis of Embryonic Rhabdomyosarcoma, Relies upon the HMGA2–IGF2BP2 Pathway
Year: 2023
Type: supplementary-materials
Abstract: PDF file - 102K, Contains supplemental information regarding antibodies used, cell growth and apoptosis assays, a tissue expression profile, microarray analysis and statistics.
Institution: Duke University
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361809416